Adia Nutrition Inc (PK) (ADIA) News

Pump and dump

Possibility!

Waiting for $1.00+

Hit .095 Today!

Nice volume came in this afternoon.

Would like to see this back over .10 next week!

$ADIA

dome decent buys coming in at 09 this afternoon

Accumulation

Some interesting buying coming now. All buys today, so far:

A whopping $117 of prop volume to keep the price at .09. I bet none of you pumpers even know the annual report came out this week. That or you dont want to mention it because it states theyll need money and will need to use the Reg A at .005

$ADIA churning green here. just a matter of time before this breaks out.

Plus the company is working with a PCAOB-registered accounting firm to complete a third-party audit—the first step in its plan to uplist to OTCQB and eventually Nasdaq Small Cap!

Here’s why this matters:

✅ OTCQB uplisting = More credibility & transparency 📊
✅ Increased liquidity = More trading volume, stronger price action 💰
✅ Bigger investor base = Institutional money on the horizon 💵
✅ Roadmap to Nasdaq Small Cap is in place 🚀

Way overbought and pumped. Looks like someone bought 100 shares at the close to paint the mark.

$ADIA is +1,320.00% on its 50 DMA!

ADIA Continues to Scale Up! >>

Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion
https://www.newsfilecorp.com/release/243941/Adia-Nutrition-Hunts-for-Top-Sales-Talent-to-Power-Adia-Med-and-Adia-Labs-Expansion

PR'ng job postings? Why?

That's the kind of news I really wanted to see.

news https://www.otcmarkets.com/stock/ADIA/news/Adia-Nutrition-Hunts-for-Top-Sales-Talent-to-Power-Adia-Med-and-Adia-Labs-Expansion?id=470454

$ADIA Up On The Day! Great loading opps out here!

Adia has undergone a major transformation—shifting from nutritional supplements to stem cell research & regenerative medicine. The company recently launched its first clinic and is already planning expansions.

📊 Technical indicators suggest upside:
✔ Trading above all key SMAs (8, 20, 50, 200-day)
✔ MACD & accumulation trends pointing bullish
✔ RSI at 58.71—showing strength without overbought conditions
✔ Resistance at $0.09 tested multiple times, with upside potential to $0.12–$0.15

With growing institutional interest in stem cell therapy, will $ADIA retest its 52-week high of $0.1720? Keep it on your watchlist! 🚀 #Biotech #StemCell #ADIA

yep

Weird how no one here posted about the annual filing filed yesterday. Over $200k net loss and said they'll need to use the Reg A for funding. Why did no one even talk about it today? Oh because everyone posting here is paid to be here and push this on unsuspecting buyers. It doesn't work anymore.

Plans for nationwide expansion.

Yup, staying on track. Expansion happening

It's just a matter of time before $ADIA breaks out!

agreed

Great stream of news by the company, here's today's press release! >>

ADIA Nutrition Strengthens Team to Optimize Operations and Advance Regenerative Medicine Excellence
Winter Park, Florida--(Newsfile Corp. - March 11, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in healthcare innovation and regenerative medicine, is proud to announce the expansion of its workforce with two strategic hires designed to enhance operations and elevate standards in stem cell therapy. These additions reflect ADIA Nutrition's dedication to scaling its Adia Med division with efficiency and innovation as it grows nationwide.

ADIA Nutrition has welcomed a skilled intake nurse to manage patient-facing responsibilities at the Adia Med Winter Park Clinic. At this location, she will handle traditional intake duties meanwhile assisting doctors with patient assessments, medical history reviews, and treatment plan coordination, ensuring a seamless experience for clients seeking regenerative therapies. Beyond Winter Park, she will work directly with doctors to create compliance standards and write best practices for stem cell treatments across all Adia Med locations, relieving them of some administrative workload. This support allows physicians to focus on developing the best procedures for patients and continuously improving the effectiveness of regenerative medicine, ensuring consistent quality and regulatory alignment as the company expands.

Additionally, ADIA Nutrition has promoted Larry Powalisz's intern of three years into a role as the CEO's aide. This trusted team member will take on many individual projects previously managed by Powalisz, including handling marketing efforts and social media strategy, significantly reducing the CEO's day-to-day responsibilities. This shift relieves Powalisz from dealing with specific project details, enabling him to concentrate on the bigger picture—maximizing the reach and success of ADIA Nutrition as it expands its influence in the healthcare sector.

"These hires are a massive boost for ADIA Nutrition," said Larry Powalisz, CEO of ADIA Nutrition. "Our new intake nurse will deliver top-tier care at Winter Park while partnering with our doctors to set compliance and stem cell standards, freeing them to innovate for our patients. Meanwhile, my aide taking on projects, marketing, and social media lets me focus on driving our broader vision and expanding our brand. Together, they're powering our growth and pushing regenerative medicine forward."

These hires come on the heels of ADIA Nutrition's recent successes, including the profitable launch of the Adia Med Winter Park Clinic and plans for nationwide expansion. The intake nurse's collaboration with doctors on compliance and standards will ensure scalable, high-quality care, while the CEO's aide enhances operational agility and visibility, solidifying ADIA Nutrition's leadership in delivering cutting-edge, accessible regenerative therapies.

For questions, inquiries, or further information, contact Larry Powalisz at ceo @101Dahlias-0850.

About ADIA Nutrition Inc.:
ADIA Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, it operates two key divisions: a supplement division offering premium, organic supplements, and a medical division establishing clinics specializing in leading-edge stem cell therapies, including Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these efforts, ADIA Nutrition empowers individuals to live their best lives by addressing nutritional needs and groundbreaking medical treatments.

Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition

https://finance.yahoo.com/news/adia-nutrition-strengthens-team-optimize-141500079.html

$ADIA

Nice update out. Additionally, ADIA Nutrition’s CEO, Larry Powalisz, has promoted his longtime intern to aide, offloading key projects, marketing, and social media. This change allows leadership to focus on strategic expansion while maintaining our mission-driven approach.

"Adia will alway do what is in the best interest of the company and Adia's shareholders."

news https://www.otcmarkets.com/stock/ADIA/news/ADIA-Nutrition-Strengthens-Team-to-Optimize-Operations-and-Advance-Regenerative-Medicine-Excellence?id=470175

ADIA Nutrition Strengthens Team to Optimize Operations and Advance Regenerative Medicine Excellence

Agreed. Once volume steps back in it will be an easy push past .10 and higher.

✔ Trading above all key SMAs (8, 20, 50, 200-day)
✔ MACD & accumulation trends pointing bullish
✔ RSI at 58.71—showing strength without overbought conditions
✔ Resistance at $0.09 tested multiple times, with massive upside potential

Stay hungry 🤘

What's up mofos! Bring on March madness 🔥 

Congratulations!

From the annual report:

Management plans to utilize the funding resources it has available (i.e., its line of credit facility) as well as the continued identification of adequate sources of funding to provide operating capital for continued growth. The Company plans to continue the use of its Reg A filing to raise additional capital; the Company has received $40,000 in investments towards this registration during the years ended
December 31, 2024.


That offering is priced at .005......

100k bidder @ 07!

$ADIA

Nice bid building there!

$ADIA

Check out the huge bids setting up at .07. Very nice!
$ADIA

51K and I had the misfortune of having bought some 30K of them.

This YouTube short video about the CEO explaining why he started Adia Med is really inspiring and a must listen! $ADIA
Why I Started Adia Med A CEO’s Personal Drive to Cure MS #ahsct #stemce... https://t.co/3lfuz37DVC via @YouTube— Adia Nutrition (@ADIA_Nutrition) March 7, 2025

$ADIA

I agree BCN! Once volume starts pouring in $ADIA is ready for takeoff!

Volume = interest. For some reason interest is gone for now. I think investors are waiting for proof that this company has a future. Numbers don't lie. Time will tell.

It is!!!

I thought anything under .10 was a steal? Why arent you buying?

yea we need vol

.09 up this morning. I have some bids set just in case, but if volume hits ADIA will go over .10 quickly.

Unfortunately, the interest has been suppressed. Everytime it tries to get past 9's someone dumps at the bid.

Hopefully, this changes soon and the volume picks up.

Nice bid support in the 06s

$ADIA

lets break 10 today and not look back